Cellectar Biosciences, Inc. Prepaid Expense and Other Assets, Current
Cellectar Biosciences, Inc. (CLRB) had Prepaid Expense and Other Assets, Current of $883.66 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense and Other Assets, Current $883.66K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $920.04K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $842.43K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $1.07M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $883.66K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $920.04K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $842.43K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $1.07M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.58M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $987.50K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $961.66K 10-K · filed 2026-03-04 | |
| 2024-09-30 | $1.64M 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $2.04M 10-Q · filed 2024-10-29 | |
| 2024-03-31 | $1.34M 10-Q/A · filed 2024-10-29 | |
| 2023-12-31 | $888.23K 10-K · filed 2025-03-13 | |
| 2023-09-30 | $1.12M 10-K/A · filed 2024-10-29 | |
| 2023-06-30 | $456.68K 10-K/A · filed 2024-10-29 | |
| 2023-03-31 | $1.16M 10-K/A · filed 2024-10-29 | |
| 2022-12-31 | $663.24K 10-K/A · filed 2024-10-29 | |
| 2022-09-30 | $975.94K 10-K/A · filed 2024-10-29 | |
| 2022-06-30 | $479.67K 10-K/A · filed 2024-10-29 | |
| 2022-03-31 | $760.42K 10-K/A · filed 2024-10-29 | |
| 2021-12-31 | $867.49K 10-K · filed 2023-03-09 | |
| 2021-09-30 | $1.05M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $347.03K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $774.89K 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $774.43K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $960.91K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $593.59K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $771.34K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $770.95K 10-K · filed 2021-03-02 | |
| 2019-09-30 | $1.45M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.33M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $604.65K 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $641.22K 10-K · filed 2020-03-09 | |
| 2018-09-30 | $685.97K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $780.56K 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $770.01K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $412.17K 10-K · filed 2019-02-26 | $878.00K 10-K · filed 2018-03-21 |
| 2017-09-30 | $970.24K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $969.59K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $893.18K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $693.57K 10-K · filed 2018-03-21 | |
| 2016-09-30 | $437.60K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $162.22K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $281.44K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $267.78K 10-K · filed 2017-03-15 | |
| 2015-09-30 | $445.28K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $118.59K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $171.03K 10-Q · filed 2015-05-20 | |
| 2014-12-31 | $220.61K 10-K/A · filed 2016-10-20 | |
| 2014-09-30 | $290.35K 10-Q · filed 2015-05-20 | |
| 2014-06-30 | $334.98K 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $212.34K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $294.69K 10-Q · filed 2015-05-20 | |
| 2013-09-30 | $329.35K 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $147.37K 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $191.84K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $327.39K 10-K · filed 2014-03-19 | |
| 2012-09-30 | $335.98K 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $138.99K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $183.30K 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $254.97K 10-K · filed 2013-03-28 | |
| 2011-09-30 | $303.63K 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $53.12K 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $51.04K 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |